Who is sponsoring NCT04638569?

NCT04638569 is sponsored by Muğla Sıtkı Koçman University.

What drugs are being tested in NCT04638569?

Interventions in NCT04638569: obturator nerve block.

What condition does NCT04638569 study?

NCT04638569 studies Succesful Obturator Nerve Block, Bladder Tumor, Bleeding.

Is NCT04638569 still recruiting?

NCT04638569 is currently status unknown. Last updated 7 February 2022.

Last reviewed 2022-02-07 · How we verify

NCT04638569

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs

Status unknown NA Last updated 7 February 2022

What this trial tests

NA trial testing obturator nerve block in Succesful Obturator Nerve Block in 116 participants. Status unknown.

Timeline

16 February 2021

Primary endpoint
1 March 2022

1 September 2022

Quick facts

Lead sponsor	Muğla Sıtkı Koçman University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	other
Enrollment	116
Start date	16 February 2021
Primary completion	1 March 2022
Estimated completion	1 September 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

obturator nerve block

Conditions studied

Succesful Obturator Nerve Block — all drugs for Succesful Obturator Nerve Block →
Bladder Tumor — all drugs for Bladder Tumor →
Bleeding — all drugs for Bleeding →

Sponsor

Muğla Sıtkı Koçman University

Who can join

Adults 18 to 70, any sex, with Succesful Obturator Nerve Block or Bladder Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of the obturator nerve block in patients undergoing transurethral resection due to bladder tumor, technically using ultrasound guided or blinded with anatomical signs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Trial watch: local anesthetics in cancer therapy.
Carnet Le Provost K, Kepp O, Kroemer G, Bezu L. · · 2024 · cited 5× · PMID 38504848 · DOI 10.1080/2162402x.2024.2308940

Verify or expand the search:

Other trials of obturator nerve block

Trials testing the same drug.

NCT07078773 — Application of Pericapsular Nerve Group (PENG) Block · NA · active not recruiting

Other Muğla Sıtkı Koçman University trials

Trials by the same sponsor.

NCT05046834 — Effect of Cold Application on Patient's Pain and Vital Signs During Chest Tube Removal. · NA · withdrawn
NCT07323160 — Determining the Effect of Education Given to Patients Undergoing Outpatient Anal Fistula Surgery · NA · not yet recruiting
NCT07308730 — Pain Diary Use After Laparoscopic Cholecystectomy · NA · recruiting
NCT06704399 — Psychoeducation Based on Acceptance and Commitment Therapy · NA · not yet recruiting
NCT07183956 — Comparison of the Silverman-Andersen Score and the Downes Score · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04638569 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Muğla Sıtkı Koçman University
Last refreshed: 7 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04638569.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing